Chris Austin, the new director of the National Center for Advancing Translational Sciences, is dedicated to removing the obstacles to speeding translation of research to therapies. His previous experience at the National Human Genome Research Institute and the NIH Chemical Genomics Center gives him a valuable perspective, and although NCATS is not specifically focused on genomics, the science will strongly inform the center's work. "One of the many translational bottlenecks is how do you go from the deluge of genetic data with weak associations and small effect sizes to targets that you would actually want to [work] on," Austin said.

Related Summaries